CRLF2 and acute lymphoblastic leukemia: Thus, the result of combining an IKZF1 loss of function mutation with the BCR-ABL1 oncogenic driver in Ph+ ALL or alternatively, amplified CRLF2 gene expression and JAK mutations in Ph-like ALL, is likely leukemic cells, which retain some self-renewal capability.